Jiangsu Nhwa Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Jiangsu Nhwa Pharmaceutical has a total shareholder equity of CN¥6.7B and total debt of CN¥65.2M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥7.6B and CN¥929.2M respectively. Jiangsu Nhwa Pharmaceutical's EBIT is CN¥1.1B making its interest coverage ratio -15.9. It has cash and short-term investments of CN¥3.7B.
Key information
1.0%
Debt to equity ratio
CN¥65.23m
Debt
Interest coverage ratio | -15.9x |
Cash | CN¥3.67b |
Equity | CN¥6.67b |
Total liabilities | CN¥929.21m |
Total assets | CN¥7.60b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002262's short term assets (CN¥5.5B) exceed its short term liabilities (CN¥823.5M).
Long Term Liabilities: 002262's short term assets (CN¥5.5B) exceed its long term liabilities (CN¥105.7M).
Debt to Equity History and Analysis
Debt Level: 002262 has more cash than its total debt.
Reducing Debt: 002262's debt to equity ratio has reduced from 11.8% to 1% over the past 5 years.
Debt Coverage: 002262's debt is well covered by operating cash flow (1345.2%).
Interest Coverage: 002262 earns more interest than it pays, so coverage of interest payments is not a concern.